Please login to the form below

INFOSHEET 02: Improving diversity in your patient recruitment strategy

As inclusion and diversity advocates, we design and implement recruitment strategies that break down participant barriers.

As ethnic and religious minorities remain under-represented in clinical studies globally, and enrolment remains your biggest challenge, the connection between the two shouldn’t go unnoticed.

Barriers to recruitment can be economic, linguistic, cultural, religious or physical. And in many cases, patients are referred by doctors or medical centres, which have a higher percentage of certain demographics than others. But with regulatory bodies around the world increasingly asking for evidence of drug safety and effectiveness in diverse populations, it’s vital to address these barriers in your clinical study design.

How a lack of diversity affects outcomes

Differences between people, such as:

  • age
  • gender
  • weight
  • ethnicity
  • geographical location

can affect clinical outcomes. Different groups may need alternative drug dosages, experience completely different results, and have distinctive side effects. Without a diverse participant pool, these metrics can’t be fully explored, meaning outcomes will be unknown.

Widen your participant pool to improve enrolment targets

Improving diversity in clinical studies brings huge benefits. For research companies, facilitating minority patients to enrol on your study means you’ll have a much broader patient pool to recruit participants from.

Help improve health equity and safety

By enrolling minority patients in your studies, you can improve the likelihood that they’ll benefit from the research. The results of the studies will be relevant to more segments of the population, and can help improve access to healthcare services generally, meaning better health equity for everybody. Plus, medical products are safer and more effective for a wider population when clinical research includes diverse populations.

How to design a diverse and inclusive clinical study

Developing relationships with patient advocacy groups is vital to the success of any clinical study. If your study needs to reach an established patient group, or a minority population, then you’ve got to engage community leaders, patient advocates, and key opinion leaders throughout the development process. By developing these relationships with your target population, your study will be welcomed and trusted.

At COUCH Health, we champion the need to improve diversity in clinical studies. Firstly, because we believe that there’s no excuse that this remains an issue in today’s modern world. And secondly, because clinical studies that enrol racially and ethnically diverse patients supports an increase in safe drugs for a representative patient population.

If you’d like to hear more about what we do, or would like to discuss how we could improve diversity and inclusion in your clinical studies, contact us here.

20th July 2020

Share

Tags

Company Details

COUCH Health

+44 (0) 330 995 0656

Contact Website

Address:
Suite 2.10, Jactin House
24 Hood Street
Manchester
M4 6WX
United Kingdom

Latest content on this profile

Why empathy in digital patient recruitment is vital
This is where empathy mapping can be incredibly effective.
COUCH Health
Why people join a clinical trial
To understand why people decide to take part in clinical trials, you first need to understand how people make decisions.
COUCH Health
Overcoming the digital patient recruitment challenges of connecting with patients
How many irrelevant experiences, ads, emails, direct messages have you rejected this week?
COUCH Health
Clinical trial design and how it can be used to improve the patient experience
For this article, we want to go back to basics and describe the main features of the most commonly used designs for clinical trials, why they are set-up in this way, and how they can be used to benefit the patient experience.
COUCH Health
What to do and what to avoid when writing about ethnicity
It’s always important to talk about ethnicity, especially when it comes to talking about diversity in clinical trials. It’s also important to know how to talk about ethnicity too. So, we’ve made you a step-by-step guide on what you should and shouldn’t do when talking and writing about ethnicity. Let’s get stuck in.
COUCH Health
Is your clinical trial method tried and tested with patients in mind?
As you may know, we talk about putting patients first, a lot. This means thinking about patients when discussing, writing and designing recruitment materials, whilst also using a multi-method approach. For example, there are huge benefits in using direct patient insights from advocacy groups, as well as conducting social listening exercises. If you utilise these approaches, you’re more likely to engage with the patient population as effectively as possible. This is what creates successful patient recruitment strategies. Makes sense, right?
COUCH Health